Orphazyme AS (CHIX:ORPHAC) EV-to-EBITDA : 0.03 (As of Sep. 25, 2024)

Orphazyme AS EV-to-EBITDA Chart

Orphazyme AS Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
EV-to-EBITDA	Get a 7-Day Free Trial									-	-2.71	-	-0.89	-

Competitive Comparison of Orphazyme AS's EV-to-EBITDA

For the Biotechnology subindustry, Orphazyme AS's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orphazyme AS's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Orphazyme AS's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Orphazyme AS's EV-to-EBITDA falls into.

Orphazyme AS EV-to-EBITDA Calculation

Orphazyme AS's EV-to-EBITDA for today is calculated as:

Orphazyme AS's current Enterprise Value is kr-17.82 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Orphazyme AS's EBITDA for the trailing twelve months (TTM) ended in Jun. 2022 was kr-591.94 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orphazyme AS  (CHIX:ORPHAc) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Orphazyme AS's PE Ratio for today is calculated as:

Orphazyme AS's share price for today is kr8425.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Orphazyme AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 was kr-17940.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Orphazyme AS EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Orphazyme AS's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Orphazyme AS Business Description